Dr. Rayhill Interviewed on Clinical Trials for Cluster Headache

Melissa Rayhill, MD, Assistant Professor of Neurology at the Univ. at Buffalo Jacobs School of Medicine and Biomedical Sciences and director of the headache program, was recently interviewed by MedPage Today.  In a recent study that Dr. Rayhill and colleagues presented at the American Neurological Association meeting held in October 2016, surveys of patients with cluster headache indicated that 86% were accepting of placebo control arms in preventive drug trials.  Patients were less accepting of placebo controls in surgical device or abortive drug trials, however.  Dr. Rayhill noted that patients’ lack of success with preventive measures likely influenced the higher acceptance rate of placebo in those types of studies.  She also emphasized the importance of understanding cluster headache patient preferences to properly design clinical trials for the condition since “cluster headache is one of the most painful conditions known to man.”   For further details, please see http://www.medpagetoday.com/clinical-context/migraines/60864

Melissa Rayhill, MD

Melissa Rayhill, MD